Last reviewed · How we verify
Pentoxifylline and Tocopherol
Pentoxifylline and Tocopherol is a Small molecule drug developed by Hospital Vall d'Hebron. It is currently FDA-approved. Also known as: PENTO.
At a glance
| Generic name | Pentoxifylline and Tocopherol |
|---|---|
| Also known as | PENTO |
| Sponsor | Hospital Vall d'Hebron |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation (PHASE2)
- PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients (PHASE1)
- Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE) (PHASE2)
- Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose) (PHASE2)
- Combination Therapy: Hyperbaric Oxygen and PENTOCLO for Treatment of Osteoradionecrosis of the Mandible (PHASE3)
- Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ) (PHASE3)
- Impact of Topical Pentoxifylline and Tocopherol in Treatment and Prevention of Medically-related Osteonecrosis of the Jaws (NA)
- Medication-related Osteonecrosis of the Jaw (MRONJ) Registry
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pentoxifylline and Tocopherol CI brief — competitive landscape report
- Pentoxifylline and Tocopherol updates RSS · CI watch RSS
- Hospital Vall d'Hebron portfolio CI
Frequently asked questions about Pentoxifylline and Tocopherol
What is Pentoxifylline and Tocopherol?
Pentoxifylline and Tocopherol is a Small molecule drug developed by Hospital Vall d'Hebron.
Who makes Pentoxifylline and Tocopherol?
Pentoxifylline and Tocopherol is developed and marketed by Hospital Vall d'Hebron (see full Hospital Vall d'Hebron pipeline at /company/hospital-vall-d-hebron).
Is Pentoxifylline and Tocopherol also known as anything else?
Pentoxifylline and Tocopherol is also known as PENTO.
What development phase is Pentoxifylline and Tocopherol in?
Pentoxifylline and Tocopherol is FDA-approved (marketed).
Related
- Manufacturer: Hospital Vall d'Hebron — full pipeline
- Also known as: PENTO
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing